ConductScience.org, home

Paper30178490

Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?

Eichler HG and 11 others. Clin Pharmacol Ther, 2019. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals? Papers, record 30178490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30178490

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.8
iCite
Revised in PubMed
2026-10-09
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eichler HGHans-Georg
2Bloechl-Daum BBrigitte
3Broich KKarl
4Kyrle PAPaul Alexander
5Oderkirk JJillian
6Rasi GGuido
7Santos Ivo RRuihttps://orcid.org/0000-0001-8400-0013
8Schuurman AAd
9Senderovitz TThomas
10Slawomirski LLuke
11Wenzl MMartin
12Paris VValerie

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Delivery of Health CareMajor topic
Drug DevelopmentMajor topic
Drug IndustryMajor topic
Electronic Health RecordsMajor topic
Learning Health SystemMajor topic
Decision Making
Humans
International Cooperation
Randomized Controlled Trials as Topic
Technology Assessment, Biomedical

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129025140Policies and strategies to facilitate secondary use of research data in the health sciences.Int J Epidemiol2017https://conductscience.org/library/papers/29025140PubMed
223484796Dabigatran and postmarketing reports of bleeding.N Engl J Med2013https://conductscience.org/library/papers/23484796PubMed
38634569Why we need observational studies to evaluate the effectiveness of health care.BMJ1996https://conductscience.org/library/papers/8634569PubMed
424616204The European Medicines Agency's use of prioritised independent research for best evidence in regulatory action on diclofenac.Pharmacoepidemiol Drug Saf2014https://conductscience.org/library/papers/24616204PubMed
514585769Evaluating medication effects outside of clinical trials: new-user designs.Am J Epidemiol2003https://conductscience.org/library/papers/14585769PubMed
627504911Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK.Diabet Med2017https://conductscience.org/library/papers/27504911PubMed
718056625Immortal time bias in pharmaco-epidemiology.Am J Epidemiol2008https://conductscience.org/library/papers/18056625PubMed
824751815Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee.Nat Rev Drug Discov2014https://conductscience.org/library/papers/24751815PubMed
929327451Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP).Pharmacoepidemiol Drug Saf2018https://conductscience.org/library/papers/29327451PubMed
1025594052The combinatorial complexity of cancer precision medicine.Oncoscience2014https://conductscience.org/library/papers/25594052PubMed
1127650716"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?Clin Pharmacol Ther2016https://conductscience.org/library/papers/27650716PubMed
1241224245Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP).Pharmacoepidemiol Drug Saf2025https://conductscience.org/library/papers/41224245PubMed
1329159410Use of Health Care Databases to Support Supplemental Indications of Approved Medications.JAMA Intern Med2018https://conductscience.org/library/papers/29159410PubMed
1427049302'You should at least ask'. The expectations, hopes and fears of rare disease patients on large-scale data and biomaterial sharing for genomics research.Eur J Hum Genet2016https://conductscience.org/library/papers/27049302PubMed
1528912202Blockchain Technology: Applications in Health Care.Circ Cardiovasc Qual Outcomes2017https://conductscience.org/library/papers/28912202PubMed
1629047353Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness.Crit Care2017https://conductscience.org/library/papers/29047353PubMed
1728864726From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely.Clin Cancer Res2017https://conductscience.org/library/papers/28864726PubMed
1821720406Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response.Nat Rev Drug Discov2011https://conductscience.org/library/papers/21720406PubMed
1920681003A basic study design for expedited safety signal evaluation based on electronic healthcare data.Pharmacoepidemiol Drug Saf2010https://conductscience.org/library/papers/20681003PubMed
2026883990Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.Nat Commun2016https://conductscience.org/library/papers/26883990PubMed

See all 25 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
41742923Advancing Decision Support Systems with Data, Informatics, and Learning Health Systems in a Post-Meaningful Use Era.Mo Med2026https://conductscience.org/library/papers/41742923PubMed
41097687Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.Cancers (Basel)2025https://conductscience.org/library/papers/41097687PubMed
40408373Evaluating the effectiveness of data governance frameworks in ensuring security and privacy of healthcare data: A quantitative analysis of ISO standards, GDPR, and HIPAA in blockchain technology.PLoS One2025https://conductscience.org/library/papers/40408373PubMed
39331958User Requirements for an Electronic Patient Recruitment System: Semistructured Interview Analysis After First Implementation in 3 German University Hospitals.JMIR Hum Factors2024https://conductscience.org/library/papers/39331958PubMed
38249849Learning healthcare systems in cardiology: A qualitative interview study on ethical dilemmas of a learning healthcare system.Learn Health Syst2024https://conductscience.org/library/papers/38249849PubMed
38239190Current trends and future prospects of drug repositioning in gastrointestinal oncology.Front Pharmacol2023https://conductscience.org/library/papers/38239190PubMed
38186562
High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease: A Clinical Research Protocol.
Can J Kidney Health Dis2024https://conductscience.org/library/papers/38186562PubMed
36401303How can artificial intelligence optimize value-based contracting?J Pharm Policy Pract2022https://conductscience.org/library/papers/36401303PubMed
36091761How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer.Front Pharmacol2022https://conductscience.org/library/papers/36091761PubMed
35970673Translating periodontal data to knowledge in a learning health system.J Am Dent Assoc2022https://conductscience.org/library/papers/35970673PubMed
35677639Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy.Clin Ophthalmol2022https://conductscience.org/library/papers/35677639PubMed
35502197Mapping Outcomes and Registries Used in Current Danish Pharmacoepidemiological Research.Clin Epidemiol2022https://conductscience.org/library/papers/35502197PubMed
35444533Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan.Front Pharmacol2022https://conductscience.org/library/papers/35444533PubMed
35397194A vision for integrated publicly available information on regulated medical products.Clin Transl Sci2022https://conductscience.org/library/papers/35397194PubMed
35325976[Research advances of real world study in the field of chronic wound].Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi2022https://conductscience.org/library/papers/35325976PubMed
35298789Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment.Ophthalmol Ther2022https://conductscience.org/library/papers/35298789PubMed
35230148Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.J Ocul Pharmacol Ther2022https://conductscience.org/library/papers/35230148PubMed
35099393Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study.JMIR Med Inform2022https://conductscience.org/library/papers/35099393PubMed
34867312
A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges.
Front Pharmacol2021https://conductscience.org/library/papers/34867312PubMed
34789314
Evaluating Diuretics in Normal Care (EVIDENCE): protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension.
Trials2021https://conductscience.org/library/papers/34789314PubMed

See all 39 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F82157PubTator's text mininghttps://conductscience.org/library/genes/2157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30178490

GET https://conductscience.org/api/papers/v1/30178490/references?page=2